Home » Market News » DirectorsTalk Highlights » 5 Things Selena Gomez’s Battle With Lupus Have Taught Us About the Autoimmune Disease
Immupharma Plc

5 Things Selena Gomez’s Battle With Lupus Have Taught Us About the Autoimmune Disease

Growing up in the spotlight can be tough, just ask Disney-star-turned-pop-singer Selena Gomez. The 26-year-old has been candid about the challenges that come with the attention (and has taken a couple of social media hiatuses to deal, as she explained in a 2018 Instagram post preceding one such break).

But Gomez has also embraced her celebrity as a way to educate fans about being diagnosed with and living with lupus, a sometimes debilitating chronic condition.

Lupus is an autoimmune disease that commonly affects the skin, joints, and kidneys. Instead of warding off infection and disease to keep the body healthy, the immune systems of people with lupus attack healthy tissues in the body. The signs and symptoms of lupus are not always present. Rather, there are episodes, called flares, when symptoms worsen.

ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need,Low marketing costs and Relatively low development costs

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.